262 related articles for article (PubMed ID: 9723243)
1. High performance liquid chromatography cyclosporine monitoring: a predictor of renal graft outcome.
Cicciarelli J; Avila D; Iwaki Y; Sather H; Mendez R
Transplant Proc; 1998 Aug; 30(5):1683-4. PubMed ID: 9723243
[No Abstract] [Full Text] [Related]
2. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice.
Vathsala A; Lu YM
Transplant Proc; 2001; 33(7-8):3137-9. PubMed ID: 11750348
[No Abstract] [Full Text] [Related]
3. Low exposure to cyclosporine is a risk factor for the occurrence of chronic rejection after kidney transplantation.
Citterio F; Torricelli P; Serino F; Foco M; Pozzetto U; Fioravanti P; Castagneto M
Transplant Proc; 1998 Aug; 30(5):1688-90. PubMed ID: 9723245
[No Abstract] [Full Text] [Related]
4. Variability of Sandimmune pharmacokinetics in renal transplant patients.
Wingerchuk C; Heim-Duthoy KL; Macres MG; Kasiske BL
Transplant Proc; 1998 Aug; 30(5):1656-7. PubMed ID: 9723230
[No Abstract] [Full Text] [Related]
5. Cyclosporine lymphocyte level and lymphocyte count: new guidelines for tailoring immunosuppressive therapy.
Barbari A; Stephan A; Masri M; Mourad N; Kamel G; Kilani H; Karam A; Daya IA
Transplant Proc; 2003 Nov; 35(7):2742-4. PubMed ID: 14612101
[No Abstract] [Full Text] [Related]
6. Effect of variability of cyclosporine pharmacokinetics on long-term renal allograft survival.
Markell MS; Homel P; Sumrani N; Hong JH; Distant DA; Miles AM; Sommer BG; Friedman EA
Transplant Proc; 1998 Aug; 30(5):1980-2. PubMed ID: 9723360
[No Abstract] [Full Text] [Related]
7. A two-year study of the new cyclosporine formulation Consupren in de novo renal transplant patients.
Stephan AG; Barbari A; Masri M; Kamel G; Barakat Khoury W; Karam A; Mokhbat J; Kilany H
Transplant Proc; 1998 Nov; 30(7):3563-4. PubMed ID: 9838560
[No Abstract] [Full Text] [Related]
8. C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients.
Citterio F; Scatà MC; Borzi MT; Pozzetto U; Castagneto M
Transplant Proc; 2001; 33(7-8):3133-6. PubMed ID: 11750347
[No Abstract] [Full Text] [Related]
9. Optimization of cyclosporine therapy with abbreviated area under the curve method in renal transplant.
Yang WC; Chen YF; King KL; Wu TH; Chen Hsu RY ; Tang JJ; Loong CC; Chou MH; Lin MF; Lui WY
Transplant Proc; 2000 Nov; 32(7):1685-7. PubMed ID: 11119892
[No Abstract] [Full Text] [Related]
10. Relationship between maintenance dose of cyclosporine and long-term kidney graft survival. Collaborative Transplant Study.
Opelz G
Transplant Proc; 1998 Aug; 30(5):1716-7. PubMed ID: 9723253
[No Abstract] [Full Text] [Related]
11. Effects of calcium channel blockers in renal allograft patients receiving cyclosporine.
Suh BY; Kwun OS; Kwun KB
Transplant Proc; 1998 Nov; 30(7):3558-60. PubMed ID: 9838558
[No Abstract] [Full Text] [Related]
12. Acute allograft rejection following conversion to a new cyclosporine formulation in pediatric renal transplant patients.
Crocker J; Renton K; Wade A; McLellan H; Acott P
Transplant Proc; 1998 Aug; 30(5):2002-5. PubMed ID: 9723369
[No Abstract] [Full Text] [Related]
13. Greater variability of dose-corrected cyclosporine C2 concentrations in renal recipients with acute rejection.
Chueh SC; Liao CH; Lai MK
Transplant Proc; 2003 Feb; 35(1):234-5. PubMed ID: 12591378
[No Abstract] [Full Text] [Related]
14. Drug monitoring of mycophenolic acid in the early period after renal transplantation.
Krumme B; Wollenberg K; Kirste G; Schollmeyer P
Transplant Proc; 1998 Aug; 30(5):1773-4. PubMed ID: 9723276
[No Abstract] [Full Text] [Related]
15. Is the lower cyclosporine concentration at 2 hours after dosing safe in kidney transplant recipients?
Einollahi B; Rostami Z; Kalantar E; Lessan-Pezeshki M; Pourfarziani V; Nemati E
Transplant Proc; 2011 Mar; 43(2):488-90. PubMed ID: 21440741
[TBL] [Abstract][Full Text] [Related]
16. Neoral (cyclosporine) C2 monitoring in renal transplant recipients: a single-center experience in Asia.
Wong HS; Morad Z
Transplant Proc; 2003 Feb; 35(1):230-1. PubMed ID: 12591376
[No Abstract] [Full Text] [Related]
17. Preservation of renal function during maintenance therapy with cyclosporine.
Serón D; Moreso F
Transplant Proc; 2004 Mar; 36(2 Suppl):257S-260S. PubMed ID: 15041349
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine absorption profiling and therapeutic drug monitoring using C(2) blood levels in stable renal allograft recipients.
Einecke G; Mai I; Diekmann F; Fritsche L; Neumayer HH; Budde K
Transplant Proc; 2002 Aug; 34(5):1738-9. PubMed ID: 12176557
[No Abstract] [Full Text] [Related]
19. Three-hour postdose cyclosporine level monitoring: less rejection and more nephrotoxicity?
Domínguez J; Tomic A; Norambuena R
Transplant Proc; 2001; 33(7-8):3120-1. PubMed ID: 11750341
[No Abstract] [Full Text] [Related]
20. Role of postdose cyclosporine monitoring in living renal transplant recipients.
Thomas R; Minz M; Singh B; Heer M; Kashyap R
Transplant Proc; 2004 Sep; 36(7):2104. PubMed ID: 15518761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
